168 related articles for article (PubMed ID: 30205104)
1. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis.
Chow AK; Kahan AN; Hwang T; Coogan CL; Latchamsetty KC
Urology; 2018 Dec; 122():127-132. PubMed ID: 30205104
[TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
[TBL] [Abstract][Full Text] [Related]
3. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
[TBL] [Abstract][Full Text] [Related]
4. Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
Iizuka J; Kondo T; Hashimoto Y; Kobayashi H; Ikezawa E; Takagi T; Omae K; Tanabe K
Int J Urol; 2012 Nov; 19(11):980-6. PubMed ID: 22735049
[TBL] [Abstract][Full Text] [Related]
5. Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.
Kaiser A; Davenport MS; Hafez KS; Alva A; Bailey JJ; Francis IR
AJR Am J Roentgenol; 2018 May; 210(5):1088-1091. PubMed ID: 29489406
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Trifecta and Pentafecta Outcomes between T1a and T1b Renal Masses following Robot-Assisted Partial Nephrectomy (RAPN) with Minimum One Year Follow Up: Can RAPN for T1b Renal Masses Be Feasible?
Kim DK; Kim LH; Raheem AA; Shin TY; Alabdulaali I; Yoon YE; Han WK; Rha KH
PLoS One; 2016; 11(3):e0151738. PubMed ID: 26987069
[TBL] [Abstract][Full Text] [Related]
7. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
8. Single-Institution Experience with Robotic Partial Nephrectomy for Renal Masses Greater Than 4 cm.
Janda G; Deal A; Yang H; Nielsen M; Smith A; Pruthi RS; Wallen E; Woods M; Raynor M
J Endourol; 2016 Apr; 30(4):384-9. PubMed ID: 26597172
[TBL] [Abstract][Full Text] [Related]
9. Chest X-ray in the follow-up of renal cell carcinoma.
Doornweerd BH; de Jong IJ; Bergman LM; Ananias HJ
World J Urol; 2014 Aug; 32(4):1015-9. PubMed ID: 24096433
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
11. Nephron Sparing Surgery Has Better Oncologic Outcomes Than Extirpative Nephrectomy in T1a but Not in T1b or T2 Stage Renal Cell Carcinoma.
Luo Y; Chen SS; Bai L; Luo L; Zheng XG; Wang S
Med Sci Monit; 2017 Jul; 23():3480-3488. PubMed ID: 28717119
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.
Patard JJ; Shvarts O; Lam JS; Pantuck AJ; Kim HL; Ficarra V; Cindolo L; Han KR; De La Taille A; Tostain J; Artibani W; Abbou CC; Lobel B; Chopin DK; Figlin RA; Mulders PF; Belldegrun AS
J Urol; 2004 Jun; 171(6 Pt 1):2181-5, quiz 2435. PubMed ID: 15126781
[TBL] [Abstract][Full Text] [Related]
13. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
Levy DA; Slaton JW; Swanson DA; Dinney CP
J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
[TBL] [Abstract][Full Text] [Related]
14. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.
Chen XS; Zhang ZT; Du J; Bi XC; Sun G; Yao X
Urology; 2012 Apr; 79(4):836-9. PubMed ID: 22305422
[TBL] [Abstract][Full Text] [Related]
15. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
17. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.
Adibi M; Kenney PA; Thomas AZ; Borregales LD; Nogueras-González GM; Wang X; Devine CE; Karam JA; Wood CG
Eur Urol; 2016 Feb; 69(2):352-60. PubMed ID: 26382085
[TBL] [Abstract][Full Text] [Related]
19. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
20. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
